Order Article Reprints

Ocak T, Yağız B, Ocak B, Yoğurtçu Ö, Başıbüyük F, Tezcan D, Ermurat S, İnanç E, Yamancan G, Albayrak F, et al. Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. Journal of Clinical Medicine. 2024; 13(20):6216. https://doi.org/10.3390/jcm13206216

Ocak, Tuğba, Burcu Yağız, Birol Ocak, Özge Yoğurtçu, Fatma Başıbüyük, Dilek Tezcan, Selime Ermurat, Elif İnanç, Gülşah Yamancan, Fatih Albayrak, and et al. 2024. "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey" Journal of Clinical Medicine 13, no. 20: 6216. https://doi.org/10.3390/jcm13206216

Ocak, T., Yağız, B., Ocak, B., Yoğurtçu, Ö., Başıbüyük, F., Tezcan, D., Ermurat, S., İnanç, E., Yamancan, G., Albayrak, F., Sağır, R. P., Bayındır Akbaş, A. N., Cüre, O., Coşkun, B. N., Yolbaş, S., Karasu, U., Kısacık, B., Koca, S. S., Sarı, İ., ... Pehlivan, Y. (2024). Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. Journal of Clinical Medicine, 13(20), 6216. https://doi.org/10.3390/jcm13206216